IP Library Granted Patent US 11,426,083
Granted Patent B2
US 11,426,083 · App. 16/471,823 · Granted Aug 30, 2022

Equipment for monitoring blood flow and respiratory flow

Inventors: Phillippe Lange (Liège, BE); Giovanni Amoroso (Haarlem, NL); David Lawrence Camp (Kampenhout, BE); Gabriele Buttignol (Grevenmacher, LU); Gerrit de Vries (Kampenhout, BE)
Assignee: IDA Health, Inc.
A61B5/0205A61B5/0002A61B5/0295A61B5/6833A61B5/0816A61B2562/0261
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,426,083
App. No.
16/471,823
Granted
Aug 30, 2022
Kind
B2
Abstract

The subject matter of the invention of the present application is non-invasive equipment for monitoring blood flows and/or respiratory cycles of a human or animal body, comprising at least one segment of conductive elastomer with variable resistance arranged so as to extend over the circumference of the body element and sensitive to the length of the circumference of said element, means for capturing said length by virtue of said variable resistance and supplying a signal representing said length, and means for processing said signal, comprising means for extracting parameters of the blood flows and/or respiratory cycles to be monitored.

Claims (20)

1. A wearable medical device for monitoring blood flow through a blood vessel, comprising:

at least one segment of a conductive elastomer with a variable resistance that varies in response to changes in its length, the at least one segment of the conductive elastomer being configured to elastically change length in response to:

blood flow through the blood vessel;

a circuit coupled to the at least one segment of the conductive elastomer and configured to measure a resistance of the at least one segment of the conductive elastomer as its length varies with blood flow through the blood vessel;

a clamping member for automatically adjusting a length of the at least one segment of the conductive elastomer; and

a processor in communication with the circuit and the clamping member, the processor being configured to:

correlate the measured resistance into one or more parameters of the blood flow to be monitored; and

generate at least one of an audible, visual, and tactile signal to indicate an end of an adjustment operation of the at least one segment of the conductive elastomer by the clamping member.

2. The wearable medical device according to claim 1 , wherein the at least one segment of the conductive elastomer is sized and configured to surround at least a portion of the blood vessel.

3. The wearable medical device according to claim 1 , wherein the at least one segment of the conductive elastomer is secured to an adhesive.

4. The wearable medical device according to claim 1 , wherein the circuit is a Wheatstone bridge.

5. The wearable medical device according to claim 4 , wherein the Wheatstone bridge is connected to a wireless transmitter.

6. The wearable medical device according to claim 5 , wherein the wireless transmitter is connected to a wireless receiver of the processor.

7. The wearable medical device according to claim 1 , comprising a plurality of segments of conductive elastomer.

8. The wearable medical device according to claim 7 , wherein the circuit includes at least two Wheatstone bridges each Wheatstone bridge including a segment of the plurality of segments of the conductive elastomer.

9. The wearable medical device according to claim 1 , wherein the clamping member comprises a motor controlled by processor to adjust the length of the at least one segment of the conductive elastomer.

10. The wearable medical device according to claim 1 , wherein the at least one segment of the conductive elastomer is a multilayer segment having an alternation of layers of conductive elastomer with layers of non-conductive elastomer.

11. The wearable medical device according to claim 1 , further including a rigid atraumatic conductive element coupled to the conductive elastomer, the rigid atraumatic conductive element being configured to be in direct contact with skin of a patient proximate the blood vessel and disposed between the conductive elastomer and the skin.

12. The wearable medical device according to claim 11 , wherein the rigid atraumatic conductive element is a bead.

13. The wearable medical device according to claim 1 , wherein the at least one segment of the conductive elastomer includes a plurality of conductive sections separated by at least one non-conductive section.

Priority Claims (1)
BE 2016/5953 · Dec 21, 2016 · national
Continuity (1)
Related Publication 20200093378A1 · Mar 26, 2020